U.S. Residential REITs Stock News

GRAIL announced that the FDA’s Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review its Premarket Approval application for the Galleri multi-cancer early detection blood test, which uses methylation patterns and artificial intelligence to detect cancer signals and predict their origin alongside existing screening methods. The PMA filing leans on extensive data from the PATHFINDER 2 study of 25,490 U.S. participants and over 70,000 participants from the NHS-Galleri...

BJ's Restaurants, Inc. recently reported past second-quarter 2026 results showing sales rising to US$388.89 million while net income fell to US$18.78 million, with diluted EPS from continuing operations slipping to US$0.86. Despite higher revenue and ongoing share repurchases under its long-running buyback program, the latest results underscore pressure on profitability as costs outpaced sales growth. Next, we’ll examine how rising sales but softer margins in the latest quarter may influence...

In early August 2026, iQIYI launched Undercurrent Theater, a horizontal short-form suspense drama brand featuring 10–25 minute, cinematic-quality episodes, now streaming on both its domestic and international platforms. By transplanting its Suspense Theater production discipline into a short-form format, iQIYI is aiming to turn premium micro-length suspense series into a distinct content brand that can stand apart from mainstream short-video platforms. We’ll now examine how building a...

Guidance Change and Earnings Put Henry Schein in Focus Henry Schein (HSIC) raised its 2026 sales growth outlook to a range of 4.5% to 5.5%, alongside second quarter results showing higher sales, net income, and earnings per share compared with the prior year period. See our latest analysis for Henry Schein. Henry Schein’s recent guidance increase and earnings report come alongside a 27.08% 3 month share price return and a 33.33% 1 year total shareholder return. This signals building momentum...

Constellation Energy (CEG) has become a focus for investors after it raised full year adjusted operating earnings guidance and outlined new long term power purchase agreements, alongside regulatory progress on the Crane Clean Energy Center restart. See our latest analysis for Constellation Energy. Constellation Energy’s latest guidance increase and long term contracts come after a mixed year for investors, with the share price down 26.31% year to date but supported by a three year total...

How Avnet’s latest earnings, guidance and buyback frame the stock Avnet (AVT) just released fourth quarter and full year results, issued new first quarter guidance, and confirmed progress on its multi year share repurchase plan, giving investors several fresh data points to consider. See our latest analysis for Avnet. The latest earnings, first quarter guidance and ongoing buyback come after a strong share price run, with a year to date share price return of 95.64% and a 5 year total...

In July 2026, CONMED Corporation reported past second-quarter 2026 results showing sales of US$343.49 million and net income of US$23.07 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. For the first half of 2026, CONMED grew net income to US$36.90 million despite slightly lower sales, and marginally raised its full-year GAAP net sales guidance range to US$1.36 billion–US$1.37 billion. Now we’ll examine how this earnings...

Li Auto Inc. reported past delivery results for the month and year-to-date ended July 31, 2026, delivering 30,468 vehicles in July and reaching cumulative deliveries of 1.76 billion vehicles year-to-date. These robust delivery figures underline how Li Auto’s scale and execution in the competitive Chinese new energy vehicle market are becoming increasingly important for investors assessing its operational strength. We’ll now examine how July’s 30,468 vehicle deliveries might reshape Li Auto’s...

Nurix Therapeutics (NRIX) is in focus after enrolling the first patient in its global Phase 3 DAYBreak CLL-306 trial of BTK degrader bexobrutideg with Roche, alongside a separate $10 million milestone payment from Sanofi. See our latest analysis for Nurix Therapeutics. The latest clinical and partnership milestones appear to be feeding into building momentum in Nurix Therapeutics' stock, with a 90 day share price return of 56.82% and a 1 year total shareholder return of 159.45%. This...

Why Avient’s latest earnings matter for investors Avient (AVNT) reported second quarter 2026 earnings on August 6, with higher sales, earnings and a record adjusted EBITDA margin, alongside raised full year guidance and continued debt repayment. This combination of operational and cash flow updates gives you fresh information on how the company is performing and what management currently expects for the rest of 2026. See our latest analysis for Avient. Avient’s latest earnings have arrived...

NNN REIT, Inc. recently reported its second-quarter 2026 results, showing revenue of US$244.27 million and net income of US$97.92 million, while also filing and completing follow-on common equity offerings and a broad shelf registration for multiple securities. Alongside this, the company raised its 2026 AFFO-per-share guidance, increased its quarterly dividend for the 37th consecutive year, and continued investing heavily in new properties while maintaining occupancy above 99%. With NNN...

In early August 2026, Zillow Group, Inc. reported second-quarter 2026 results showing revenue of US$772 million and a quarterly net loss of US$4 million, alongside leadership changes including the elevation of CFO Jeremy Hofmann to Chief Operating Officer & Chief Financial Officer and the appointment of Cassandra Knight as Chief Legal and Policy Officer. These updates, together with the completion of a share repurchase program totaling US$3.48 billions since 2021, highlight Zillow’s focus on...

Sarepta Therapeutics recently narrowed its 2026 total net product revenue guidance to US$1.20 billion–US$1.30 billion and reported second-quarter 2026 revenue of US$401.25 million, down from US$611.09 million a year earlier, with a quarterly net loss of US$4.89 million. Alongside weaker quarterly results, the company is undergoing leadership change with Michael Severino, M.D., a veteran of AbbVie, Amgen, and Merck, stepping in as Chief Executive Officer and joining the Board, while Sarepta...

Weaker US jobs data has pulled Treasury yields lower, which can make smaller companies look more attractive as investors search beyond the largest stocks. That is where the Financially Fit Penny Stocks screener comes in. It filters for lower-priced shares with healthier balance sheets so you are not just chasing stories. This article highlights three screened stocks that stand out on financial quality and potential resilience. The three stocks covered below are only a small sample of the...

In the past quarter, Ducommun Incorporated reported second-quarter 2026 sales of US$224.49 million and net income of US$20.40 million, with both basic and diluted earnings per share from continuing operations rising compared with a year earlier. Over the first half of 2026, Ducommun’s higher sales and sharply improved earnings, supported by a growing missile-related backlog, have drawn increased investor attention to its aerospace and defense exposure. We’ll now explore how Ducommun’s...

Post Holdings (POST) is back in focus after reporting third quarter fiscal 2026 results and updating investors on 2027 earnings expectations and capital allocation plans, including a clear tilt toward debt reduction instead of buybacks. See our latest analysis for Post Holdings. The latest earnings update and the decision to favour debt reduction over buybacks have come alongside a sharp reset in sentiment, with the share price down 12.79% on a 1 day basis and the 1 year total shareholder...

Why the new Perma-Fix partnership matters for Mirion Technologies Mirion Technologies (MIR) has moved into the spotlight after Perma-Fix Environmental Services announced a partnership with the company under the Small Business Administration’s Mentor Protégé Program, which focuses on U.S. nuclear cleanup work. See our latest analysis for Mirion Technologies. For Mirion Technologies, the partnership news comes after a mixed price run. The 1-day share price return is 4.59% and the 7-day share...

Cushman & Wakefield recently reported past second-quarter 2026 results showing sales rising to US$2,762.6 million while net income eased to US$52.7 million, alongside continued expansion of its industrial advisory capabilities in California. At the same time, the firm has highlighted rapid growth in data center and logistics real estate activity in India and broader Asia-Pacific markets, underscoring its focus on higher-growth segments of commercial property services. We'll now explore how...

Central Bancompany, Inc. recently reported its second-quarter 2026 results, with net interest income rising to US$212.78 million and net income to US$113.77 million, alongside a new US$100 million Class A share repurchase authorization and a maintained US$0.12 per-share cash dividend. Beyond higher earnings, the combination of reduced net charge-offs to US$3.02 million and fresh buyback capacity highlights management’s focus on capital returns and credit discipline. We’ll now examine how the...

Enact Holdings, Inc. recently reported second-quarter 2026 results, with revenue rising to US$317.31 million and net income reaching US$174.84 million, alongside higher earnings per share compared with a year earlier. Alongside affirming a US$0.24 per-share dividend, Enact completed a US$155.09 million buyback of 3,684,091 shares, underscoring ongoing capital returns to shareholders. Next, we’ll examine how Enact’s solid earnings and substantial share repurchases may influence its existing...

Moog stock moves after earnings beat, guidance raise and acquisition plans Moog (MOG.A) drew fresh attention after reporting third quarter results with higher sales and net income year on year, raising full year guidance and outlining plans to pursue bolt on acquisitions. See our latest analysis for Moog. The earnings beat, higher guidance and fresh talk of bolt on acquisitions come after a strong run in Moog’s stock, with the share price up 61.33% year to date and the 1 year total...

Meritage Homes (MTH) shares reacted to a softer second quarter update, as the company reported lower revenue and earnings and guided 2026 home closings and revenue to about 5% below 2025 levels. See our latest analysis for Meritage Homes. Despite the softer Q2 update and 2026 guidance, Meritage Homes shares have kept positive momentum, with the recent 90-day share price return of 19.38% and a year-to-date share price return of 12.62%. The 5-year total shareholder return of 38.35% reflects a...

Tractor Supply (TSCO) is back in focus after cutting its 2026 outlook and withdrawing its long term financial framework, as investors weigh how softer discretionary spending and higher costs could affect visibility into future earnings. See our latest analysis for Tractor Supply. The outlook cut appears to be the main driver behind Tractor Supply’s recent rebound, with a 30 day share price return of 13.57% and a 90 day share price return of 12.98% contrasting with a year to date share price...

In early August 2026, Boston Beer Company reported a Q2 earnings miss that prompted analysts to reassess the brewer’s underlying business outlook. The core tension now lies between expectations for cost savings and productivity gains and fresh concerns about softer volumes and concentrated brand exposure. Next, we’ll examine how the Q2 earnings shortfall and worries about weaker volumes may reshape Boston Beer’s investment narrative. Capitalize on the AI infrastructure supercycle with our...